439 related articles for article (PubMed ID: 16208152)
21. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
Mallion JM; Heagerty A; Laeis P
J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension.
Ruilope LM
Vasc Health Risk Manag; 2008; 4(6):1237-48. PubMed ID: 19337537
[TBL] [Abstract][Full Text] [Related]
24. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
Ruilope LM; Simpson RL; Toh J; Arcuri KE; Goldberg AI; Sweet CS
Blood Press; 1996 Jan; 5(1):32-40. PubMed ID: 8777471
[TBL] [Abstract][Full Text] [Related]
25. Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension.
Neutel JM; Smith DH; Silfani TN; Lee Y; Weber MA
J Hum Hypertens; 2006 Apr; 20(4):255-62. PubMed ID: 16397514
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
Chrysant SG; Weber MA; Wang AC; Hinman DJ
Am J Hypertens; 2004 Mar; 17(3):252-9. PubMed ID: 15001200
[TBL] [Abstract][Full Text] [Related]
28. Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials.
Heagerty AM; Mallion JM
Drugs Aging; 2009; 26(1):61-76. PubMed ID: 19102515
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.
Malacco E; Omboni S; Mallion JM; Volpe M;
High Blood Press Cardiovasc Prev; 2012 Dec; 19(4):213-22. PubMed ID: 23430666
[TBL] [Abstract][Full Text] [Related]
30. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
[TBL] [Abstract][Full Text] [Related]
31. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
Volpe M; Brommer P; Haag U; Miele C
Clin Drug Investig; 2009; 29(1):11-25. PubMed ID: 19067471
[TBL] [Abstract][Full Text] [Related]
33. The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.
Pool JL; Glazer R; Crikelair N; Levy D
Clin Drug Investig; 2009; 29(12):791-802. PubMed ID: 19888785
[TBL] [Abstract][Full Text] [Related]
34. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.
Smith DH; Dubiel R; Jones M
Am J Cardiovasc Drugs; 2005; 5(1):41-50. PubMed ID: 15631537
[TBL] [Abstract][Full Text] [Related]
35. Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.
Lewin AJ; Izzo JL; Melino M; Lee J; Fernandez V; Heyrman R
Drugs Aging; 2013 Jul; 30(7):549-60. PubMed ID: 23549909
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring.
Kereiakes DJ; Neutel J
Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):285-93. PubMed ID: 20801941
[TBL] [Abstract][Full Text] [Related]
37. The effects of irbesartan added to hydrochlorothiazide for the treatment of hypertension in patients non-responsive to hydrochlorothiazide alone.
Rosenstock J; Rossi L; Lin CS; MacNeil D; Osbakken M
J Clin Pharm Ther; 1998 Dec; 23(6):433-40. PubMed ID: 10048504
[TBL] [Abstract][Full Text] [Related]
38. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.
Barrios V; Brommer P; Haag U; Calderón A; Escobar C
Clin Drug Investig; 2009; 29(7):427-439. PubMed ID: 19499960
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
Agrawal R; Marx A; Haller H
J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
[TBL] [Abstract][Full Text] [Related]
40. Reduction of the morning blood pressure surge treated with olmesartan in Chinese patients with mild to moderate essential hypertension--a multicenter, open-label, single treatment group clinical study.
Jiao Y; Ke Y; Sun N; Wang J; Deng W; Zhu J; ;
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):653-9. PubMed ID: 22774407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]